NanoRepro AG is a global company specializing in the field of development, manufacturing and marketing of rapid diagnostics (self diagnostics) for domestic use. NanoRepro AG has its headquarters in Marburg an der Lahn and has been listed. The company is an innovative leader in self-diagnostics and currently has eleven rapid tests in the portfolio:

Ovulation test OvuQUICK, to detect when a woman will ovulate, the pregnancy test GraviQUICK, to detect early pregnancy, there is the GraviQUICK Early Pregnancy test, the menopause test MenoQUICK, the vaginal fungal test VagiQUICK, the gluten intolerance test GlutenCHECK, cholesterol test CholesterinCHECK, the fertility test for men, FertiQUICK, colorectal cancer screening test FOBCHECK , Heli-C-CHECK to test for the stomach bacteria Helicobacter pylori.

In the fourth quarter of 2010 NanoRepro AG introduced FOBCHECK, a self-test for fecal occult blood (colorectal cancer) and the Early Pregnancy Test GraviQUICK to detect pregnancy at a very early stage. In June 2011 Heli-C-CHECK was introduced on to the market. For 2012, there is a planned introduction of other rapid tests to expand the product portfolio.

To meet the high demands of customers, the scientists at NanoRepro AG work closely with renowned institutions such as the Fraunhofer Institute (IBMT) in Sulzbach and the Helmholtz Centre, as well as the Technical University in Munich. NanoRepro AG aims to be the best at anticipating the desires and needs of their customers!